XML 16 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Cash flows from operating activities:    
Net income $ 383 $ 326
Adjustments to reconcile net income to net cash provided by operating activities:    
Net gain from securities transactions (178) (1,603)
Purchases of securities (883) (1,991)
Proceeds from sales of securities 4,920 3,246
Payments to cover securities sold, not yet purchased (2,623) (2,325)
Proceeds from securities sold, not yet purchased 2,925 3,626
Changes in receivables and payables relating to securities transactions (768) (1,672)
Changes in derivative assets and liabilities (966) (171)
Gain on disposition of assets, net (3)  
Depreciation and amortization 380 385
Deferred taxes (44) 18
Other, net 48 60
Changes in other operating assets and liabilities 149 167
Net cash provided by operating activities 3,340 66
Cash flows from investing activities:    
Capital expenditures (254) (239)
Turnaround expenditures (74) (3)
Acquisition of businesses, net of cash acquired   (20)
Proceeds from sale of investments 153 422
Proceeds from disposition of businesses and assets 4 60
Net cash (used in) provided by investing activities (171) 220
Cash flows from financing activities:    
Investment segment distributions from non-controlling interests (14) 62
Partnership contributions 560 586
Partnership distributions (162) (92)
Dividends and distributions to non-controlling interests in subsidiaries (218) (81)
Proceeds from Holding Company senior unsecured notes   1,214
Repayments of Holding Company senior unsecured notes (500) (1,205)
Proceeds from subsidiary borrowings 91 1,116
Repayments of subsidiary borrowings (155) (1,477)
Other, net (5) (13)
Net cash (used in) provided by financing activities (403) 110
Effect of exchange rate changes on cash and cash equivalents and restricted cash and restricted cash equivalents 8 5
Net increase in cash and cash equivalents and restricted cash and restricted cash equivalents 2,774 401
Cash and cash equivalents and restricted cash and restricted cash equivalents, beginning of period 4,436 3,291
Cash and cash equivalents and restricted cash and restricted cash equivalents, end of period $ 7,210 $ 3,692